UK-based CRO Charnwood Molecular reveals plans for ‘significant’ expansion in 2021
Company will become sole occupier of laboratory facility in Loughborough
Read More
Tag: Charnwood Molecular
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
